Thalidomide-4-C3-NH2 hydrochloride
98%
- Product Code: 121691
CAS:
2357110-84-8
| Molecular Weight: | 351.78 g./mol | Molecular Formula: | C₁₆H₁₈ClN₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Thalidomide-4-C3-NH2 hydrochloride is primarily utilized in research and pharmaceutical development due to its potential therapeutic properties. It is often studied for its anti-inflammatory, immunomodulatory, and anti-angiogenic effects, making it a candidate for treating conditions such as certain cancers, autoimmune diseases, and inflammatory disorders. Researchers explore its ability to inhibit the production of tumor necrosis factor-alpha (TNF-α) and its role in modulating the immune system. Additionally, its structural modifications, like the addition of the C3-NH2 group, are investigated to enhance its efficacy and reduce side effects compared to the parent compound, thalidomide. This compound is also used in the synthesis of more complex molecules for targeted drug delivery systems.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £521.10 |
+
-
|
| 0.005 | 10-20 days | £1,498.15 |
+
-
|
Thalidomide-4-C3-NH2 hydrochloride
Thalidomide-4-C3-NH2 hydrochloride is primarily utilized in research and pharmaceutical development due to its potential therapeutic properties. It is often studied for its anti-inflammatory, immunomodulatory, and anti-angiogenic effects, making it a candidate for treating conditions such as certain cancers, autoimmune diseases, and inflammatory disorders. Researchers explore its ability to inhibit the production of tumor necrosis factor-alpha (TNF-α) and its role in modulating the immune system. Additionally, its structural modifications, like the addition of the C3-NH2 group, are investigated to enhance its efficacy and reduce side effects compared to the parent compound, thalidomide. This compound is also used in the synthesis of more complex molecules for targeted drug delivery systems.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :